Yuchen Liu

Yuchen Liu

Auto-generated profile, based on publicly available information

Yuchen Liu

State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, Key Laboratory of Oral Biomedicine, Ministry of Education, Hubei Key Laboratory of Stomatology, School & Hospital of Stomatology, Wuhan University, Wuhan, China

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 December 2023 in Gastroenterology Report
Verified
Journal Article
Open access
PDF file
YZYuzhu Zhang
Yuzhu Zhang
YLYu-Chen Liu
Yu-Chen Liu
TSTong Su
Tong Su
JSJiang-Nan Shi
Jiang-Nan Shi
YHYi Huang
Yi Huang
BLBo Liang
Bo Liang
The low incidence of combined hepatocellular cholangiocarcinoma (cHCC-CCA) is an important factor limiting research progression. Our study extensively included nearly three decades of relevant literature and assembled the most comprehensive database comprising 5,742 patients with cHCC-CCA. We summarized the characteristics, tumor markers, and clinical features of these patients. Additionally, we present the evolution of cHCC-CCA classification and explain the underlying rationale for these classification standards. We reviewed cHCC-CCA diagnostic advances using imaging features, tumor markers, and postoperative pathology, as well as treatment options such as surgical, adjuvant, and immune-targeted therapies. In addition, recent advances in more effective chemotherapeutic regimens and immune-targeted therapies were explored. Furthermore, we described the molecular mutation features and potential specific markers of cHCC-CCA. The prognostic value of Nestin has been proven, and we speculate that Nestin will also play a role in classification and diagnosis. However, further research is needed. Moreover, we believe that the possibility of using machine learning liquid biopsy for preoperative diagnosis and establishing a scoring system are directions for future research.

4 February 2026 in International Orthodontics
Verified
Journal Article
Closed access
YLYuchen Liu
Yuchen Liu
Tingting ZhaoTingting Zhao
Tingting Zhao
NWNannan Wang
Nannan Wang
JZJing Zhou
Jing Zhou
HHHong He
Hong He
Fang HuaFang Hua
Fang Hua

8 March 2026 in Journal of Dental Research
Verified
Journal Article
Closed access
YLY. Liu
Y. Liu
FGF. Guo
F. Guo
JBJ. Botelho
J. Botelho
ZTZ. Tao
Z. Tao
TZT. Zhao
T. Zhao
Fang HuaFang Hua
Fang Hua
Clinical need and research activities on craniofacial bone repair/regeneration (CBR) have been increasing in dentistry, and animal research provides essential support for its advancement. However, inadequate reporting in animal research contributes to avoidable research waste and limits the validation and translation of research findings. Therefore, this research-on-research study aimed to assess the reporting quality of animal research on CBR and to identify its changes over the past 2 decades. Electronic and manual searches were conducted to identify animal research regarding CBR published in 2004, 2014, and 2024. The reporting quality of included studies was assessed using a modified ARRIVE (Animal Research: Reporting In Vivo Experiments) 2.0 checklist. A multivariable generalized linear model was used to explore changes in reporting quality over time. A total of 164 studies were included. The mean (standard deviation) overall quality score (OQS; calculated by summing the scores of all checklist items) improved over time: OQS 2004 = 4.42 (1.29), OQS 2014 = 5.70 (1.72), and OQS 2024 = 6.79 (2.25). Among the included studies, “study design,” “objectives,” and “generalizability” were adequately reported. In contrast, less than 1.0% of the included studies sufficiently reported “inclusion and exclusion criteria” (0.6%; 1/164) and “protocol registration” (0.6%; 1/164). Despite the release and update of the ARRIVE guidelines, several methodological items, including “sample size” (8.5%; 14/164) and “randomization” (6.7%; 11/164), remained poorly reported. Only 18 of 164 studies (11.0%) specified the primary outcome measures, and none reported effect sizes with confidence intervals. Reporting of “ethical statements,” “data access,” and “declaration of interests” considerably improved but remained suboptimal. According to the multivariable analysis, publication year was a significant predictor of reporting quality ( P < 0.01). The reporting of CBR animal research has improved significantly during the past 2 decades. However, concerted efforts toward more complete and transparent reporting, which facilitate validation and translation, are warranted.